FDA has granted fast track designation to Biohaven’s Taldefgrobep Alfa for the treatment of spinal muscular atrophy Read more
Clover Enters into Exclusive Agreement to Commercialize Quadrivalent Seasonal Influenza Vaccine in Mainland China Read more
Capricor Therapeutics and Nippon Shinyaku Form Partnership for CAP-1002 Distribution in Japan, Treating Duchenne Muscular Dystrophy Read more
M2GEN and Zephyr AI Collaborate to Advance Cancer Treatment and Cure Discovery for Patients Read more
SYFOVRE (Pegcetacoplan Injection) Approved by FDA as the First and Only Treatment for Leading Cause of Blindness, Geographic Atrophy (GA) Read more
Teva Announces FDA Approval of AUSTEDO XR (deutetrabenazine) Extended-Release Tablets, a New Once-Daily Formulation of AUSTEDO (deutetrabenazine) Tablets Read more
FDA Accepts for Priority Review the Supplemental New Drug Application for Merck’s PREVYMIS for Prophylaxis of Cytomegalovirus Disease in Kidney Transplant Recipients at High Risk Read more
Aqilion announces pre-clinical licensing and strategic research collaboration agreement with Merck Read more